posted on 2021-08-16, 17:38authored byAziz Aiderus, Justin Y. Newberg, Liliana Guzman-Rojas, Ana M. Contreras-Sandoval, Amanda L. Meshey, Devin J. Jones, Felipe Amaya-Manzanares, Roberto Rangel, Jerrold M. Ward, Song-Choon Lee, Kenneth Hon-Kim Ban, Keith Rogers, Susan M. Rogers, Luxmanan Selvanesan, Leslie A. McNoe, Neal G. Copeland, Nancy A. Jenkins, Kenneth Y. Tsai, Michael A. Black, Karen M. Mann, Michael B. Mann
(A) 96-hour proliferation assay (n = 3, error bars SEM). (B) In vivo xenograft assay of COLO16 shNTC or shCREBBP into NSG immunodeficient mice (n = 9 per condition).